By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Microbiome technology firm Second Genome today announced the closing of a Series A financing round that raised $5 million.

The round was co-led by new investors Advanced Technology Ventures and Morgenthaler Ventures, as well as existing investors Wavepoint Ventures, Seraph Group, and individual investors.

The company, which was founded in 2009 as PhyloTech, also said that Mike Carusi of ATV and Jason Lettmann of Morgenthaler have joined its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.